Latest Conference Articles

Marsha Link, PhD, uses three words—Imagine, Prepare, and Optimize—to encourage women to assess their current leadership journey, strategically plan for advancement, and explore new opportunities for growth and impact in vision care.

A new treatment option may be on the horizon for glaucoma patients.

Optometry Times chats with Michael Chaglasian, OD, FAAO during this year's Glaucoma 360 meeting in San Francisco, California.

The event, being held at the El Conquistador Resort in Puerto Rico, is offering programs for ophthalmologists and optometrists.

Positive 42-month Cypress axial length and cSER outcomes, presented at ARVO in New Orleans, reinforce myopia control safety and efficacy of Diffusion Optics Technology™ spectacle lenses.

When interpreting study findings, take into consideration the similarity and the differences between the subjects recruited for the study versus the patient population each practitioner serves.

Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, shares highlights from his AOA 2022 presentation, "Myopia Management: One Child at a Time (Translating theory into practice)."

Blair Lonsberry, OD, MS, MEd, FAAO, shares highlights from his AOA 2022 co-presentation, "The Secondary Glaucomas: From the OD and MD Perspective," which he presented with Michael Greenwood, MD.

Denise A. Valenti, OD, FAAO, shares key highlights from her AOA 2022 presentation, "Marijuana and Driving: Your Retina and Brain."

Leslie O'Dell, OD, FAAO, shares new research around OC-01 (varenicline solution) nasal spray, presented during the AOA 2022 meeting.

Jessica Steen, OD, FAAO, shares key takeaways from her AOA 2022 presentation, "Problem Solving in Glaucoma Management."

Blair Lonsberry, MS, OD, MEd, FAAO, shares key takeaways from his AOA 2022 presentation, "Triaging Ocular Urgencies and Emergencies."

Jason Duncan, OD, FAAO, shares highlights from his AOA 2022 presentation, "Injection Basics," presented at this year's Optometry's Meeting in Chicago.

Katie Connolly, OD, shares about her presentation, “Maintaining Compliance with Medical Charting: Billing and Coding Update 2021,” which she presented during the 2022 AOA Optometry’s Meeting in Chicago.

A. Paul Chous, OD, discusses his presentation, “Current treatment of diabetes" during the AOA's Optometry Meeting.

Optometry Times'® Chief Optometric Editor Ben Casella, OD, FAAO, shares some reflections on his time so far at the 2022 AOA Optometry's Meeting in Chicago.

Richard Castillo, OD, DO, discusses the key takeaways from his presentation on carcinoma screenings for eyelids, and emphasizes why such screenings are such a critical component of primary eye care.

Justin Schweitzer, OD, shares key highlights from his presentation titled, "The OD's Role in the Management of MIGS in 2022," where he explores earlier intervention for glaucoma patients.

Bobby Saenz, OD, MS, FAAO, discusses his AOA 2022 presentation, "Extended Depth of Focus Lenses and Drops."

Richard Castillo, OD, DO, shares his expertise in, "Cryosurgery for Optometric Surgeons: A safe, noninvasive, nonaerosolizing approach to periocular lesion removal in the COVID-19 era."

Robert Reed Jr., OD, discusses his AOA 2022 presentation titled: "Migraines: Mother-of-All-Headaches."

Correcting refractive errors in infants and toddlers differs from that in adults. Ida Chung, OD, MS, FCOVD, FAAO, walks optometrists through the pearls and pitfalls of prescribing for this patient population.

At AOA 2022, Rebecca Wartman, OD, and Harvey Richmond, OD, discuss how eye care practitioners can properly and efficiently establish a telehealth program in their practice.

Denise Valenti, OD, advises on why driving under the influence of marijuana is not without visual consequences.

Other factors, besides IOP, can contribute to glaucomatous optic nerve damage

Optometrists at the forefront of ocular basal cell and squamous cell carcinomas

Sustained-release injectables may be key to addressing the greatest obstacles in glaucoma.

Oluwatosin Smith, MD, reviews different applications of minimally invasive glaucoma surgeries (MIGS) to find the best option, with the best outcome, for every patient.